Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1979 Dec;55(650):891–893. doi: 10.1136/pgmj.55.650.891

Control of hypercalcaemia in thyrotoxicosis

M K Jones, S E Papapoulos
PMCID: PMC2425690  PMID: 548953

Abstract

Two thyrotoxic patients with significant hypercalcaemia are described. The hypercalcaemia failed to suppress with hydrocortisone, propranolol and calcitonin but serum calcium fell rapidly to normal with carbimazole treatment. Both patients were subsequently treated surgically and at operation no evidence of parathyroid disease was found. Thyroid disease must be controlled before co-existing parathyroid disease is diagnosed in hypercalcaemic thyrotoxic patients.

Full text

PDF
891

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askenasi R., Demeester-Mirkine N. Urinary excretion of hydroxylysyl glycosides and thyroid function. J Clin Endocrinol Metab. 1975 Feb;40(2):342–344. doi: 10.1210/jcem-40-2-342. [DOI] [PubMed] [Google Scholar]
  2. Baxter J. D., Bondy P. K. Hypercalcemia of thyrotoxicosis. Ann Intern Med. 1966 Sep;65(3):429–442. doi: 10.7326/0003-4819-65-3-429. [DOI] [PubMed] [Google Scholar]
  3. Bouillon R., De Moor P. Parathyroid function in patients with hyper- or hypothyroidism. J Clin Endocrinol Metab. 1974 Jun;38(6):999–1004. doi: 10.1210/jcem-38-6-999. [DOI] [PubMed] [Google Scholar]
  4. Buckle R. M., Mason A. M., Middleton J. E. Thyrotoxic hypercalcaemia treated with porcine calcitonin. Lancet. 1969 Jun 7;1(7606):1128–1130. doi: 10.1016/s0140-6736(69)91646-8. [DOI] [PubMed] [Google Scholar]
  5. CLERKIN E. P., HAAS H. G., MINTZ D. H., MELONI C. R., CANARY J. J. OSTEOMALACIA IN THYROTOXICOSIS. Metabolism. 1964 Feb;13:161–171. doi: 10.1016/0026-0495(64)90129-5. [DOI] [PubMed] [Google Scholar]
  6. DAVID N. J., VERNER J. V., ENGEL F. L. The diagnostic spectrum of hypercalcemia. Case reports and discussion. Am J Med. 1962 Jul;33:88–110. doi: 10.1016/0002-9343(62)90280-2. [DOI] [PubMed] [Google Scholar]
  7. Dent C. E., Watson L. The hydrocortisone test in primary and tertiary hyperparathyroidism. Lancet. 1968 Sep 21;2(7569):662–664. doi: 10.1016/s0140-6736(68)92509-9. [DOI] [PubMed] [Google Scholar]
  8. Gordon D. L., Suvanich S., Erviti V., Schwartz M. A., Martinez C. J. The serum calcium level and its significance in hyperthyroidism: A prospective study. Am J Med Sci. 1974 Jul;268(1):31–36. doi: 10.1097/00000441-197407000-00004. [DOI] [PubMed] [Google Scholar]
  9. Parfitt A. M., Dent C. E. Hyperthyroidism and hypercalcaemia. Q J Med. 1970 Apr;39(154):171–187. [PubMed] [Google Scholar]
  10. Rude R. K., Oldham S. B., Singer F. R., Nicoloff J. T. Treatment of thyrotoxic hypercalcemia with propranolol. N Engl J Med. 1976 Feb 19;294(8):431–433. doi: 10.1056/NEJM197602192940807. [DOI] [PubMed] [Google Scholar]
  11. SATALINE L. R., POWELL C., HAMWI G. J. Supression of the hypercalcemia of thyrotoxicosis by corticosteroids. N Engl J Med. 1962 Sep 27;267:646–650. doi: 10.1056/NEJM196209272671304. [DOI] [PubMed] [Google Scholar]
  12. Twycross R. G., Marks V. Symptomatic hypercalcaemia in thyrotoxicosis. Br Med J. 1970 Jun 20;2(5711):701–703. doi: 10.1136/bmj.2.5711.701. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES